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ModelingThemitochondrial respiratory chain plays a crucial role in energymetabolism and its dysfunction is implicated in
awide range of human diseases. In order to understand the global expression of local mutations in the rate of ox-
ygen consumption or in the production of adenosine triphosphate (ATP) it is useful to have a mathematical
model inwhich the changes in a given respiratory complex are properlymodeled. Our aim in this paper is to pro-
vide thermodynamics respecting and structurally simple equations to represent the kinetics of each isolated
complexes which can, assembled in a dynamical system, also simulate the behavior of the respiratory chain, as
a whole, under a large set of different physiological and pathological conditions. On the example of the reduced
nicotinamide adenine dinucleotide (NADH)–ubiquinol–oxidoreductase (complex I) we analyze the suitability of
different types of rate equations. Based on our kinetic experiments we show that very simple rate laws, as those
often used inmany respiratory chainmodels, fail to describe the kinetic behaviorwhen applied to awide concen-
tration range. This led us to adapt rate equations containing the essential parameters of enzyme kinetic, maximal
velocities and Henri–Michaelis–Menten like-constants (KM and KI) to satisfactorily simulate these data.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The respiratory chain plays a crucial role in energy metabolism. In
many cases, it consists of four enzyme complexes which are connected
through two electron transporters, ubiquinone and cytochrome c. Three
of the respiratory complexes extrude protons from the mitochondrial
matrix into the intermembrane space liberating, step by step, the ener-
gy of the transfer of electrons from the low redox potential of the sub-
strates NADH or FADH2 to the high redox potential of oxygen, energy
then used to synthesize ATP.
It is now well documented that respiratory chain dysfunction is
responsible for a wide range of human diseases including neurodegen-
erative diseases and cancer. Respiratory chain dysfunction may also
have a possible relationship with aging [1,2] and metabolic disorders
[3]. In many cases respiratory chain dysfunctions are due to mutations
in the subunit constituting the respiratory chain complexes.Saint-Saëns, 33077 Bordeaux
ulaire et Imagerie de Synthèse,
use III, 37 Allées Jules Guesde,In order to better understand the behavior of the respiratory chain in
different physiological conditions and how the effects of pathological
mutations are expressed at the global level of oxygen consumption or
ATP synthesis it is useful to have a theoretical model of the respiratory
chain. In other words understanding the normal or pathological inter-
play between these complexes and the electron transporters in the
global functioning of the respiratory chain requires a model of each re-
spiratory complexwith a speciﬁc rate equation and then the integration
of all the rate equations into a dynamical system representing the oper-
ation of the whole oxidative phosphorylation.
Several models, with different levels of complexity, have been
established to describe the respiratory chain or its isolated complexes.
It does not enter the scope of this article to review them all. We would
just like to analyze the way in which the behavior of each individual
respiratory complex is approached in these models of the whole respi-
ratory chain. It means that we discard of our analysis all the models in
which the respiratory chain is represented by only one or two (depend-
ing on the electron entry point) equations (typically Magnus and Keizer
[4], Cortassa et al. [5] and many others). Among the remaining models
of respiratory chain two types of modeling of the individual complexes
are used. The ﬁrst signiﬁcant models were developed in the framework
of the Non-Equilibrium Thermodynamicmodel (NET) involving a linear
dependence of the ﬂux as a function of the thermodynamic forces [6–9].
The model developed by Korzeniewski and Froncisz [10,11], is a
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dynamic models, extended thereafter ([12,13]).
Another approach, largely used tomodel the isolated respiratory com-
plexes is the Mass Action Law (MAL), with the forward rate proportional
to the product of substrates and the backward proportional to the prod-
uct of products of the reaction. Bohnensack [14] was probably the ﬁrst
to derive a quantitative model of the respiratory chain involving nearly
all the components of oxidative phosphorylation. In this approach the re-
spiratory complexes were modeled according to the Mass-Action law. A
recent example of this approach was proposed by Beard [15].
The advantage of both approaches (NET and MAL) is that they use
very simple rate laws for each of the complexes with only one parame-
ter to adjust. But these equations cannot reﬂect the respiratory com-
plexes' behaviors over a wide range of physiological conditions as it
will be shown later in this paper.
As a matter of fact, the behavior of the individual complexes is rather
complex for several reasons: (i) the mechanisms catalyzed by each sepa-
rate complex are complex in themselves. Themost illustrating example is
the Q-cycle operating in complex III with two different quinone binding
sites and the bifurcation of the electrons coming from the QH2 molecule
into two pathways. The case of cytochrome c oxidase (complex IV) also
involves a complex synchronization between the 4 electrons necessary
to reduce oxygen inwater and the protons pumping. The case of complex
I is not yet entirely resolved but already includes a cascade of 7 or 8 ele-
mentary redox reactions. (ii) Not only substrates, products andmodiﬁers
play a role in the kinetics but also the electrochemical proton gradient
which has an important inﬂuence on the activity of each complex and
thus on the whole respiratory chain. (iii) The regulation of the activity
of these complexes depends on allosteric conformations or on chemical
modiﬁcations such as phosphorylation and acetylation [16–19].
On the one hand, the derivation of equations describing very pre-
cisely the underlying mechanisms of the respiratory complexes often
involves a huge number of parameters which are hard or impossible
to determine experimentally and will be in any case underdetermined
[20,21]. On the other hand, the experimental kinetics of these com-
plexes show, most of the time, the traditional pattern of enzymatic
kinetics i.e. saturation behavior. Furthermore, the recorded kinetics
have been analyzed with the usual phenomenological approaches of
enzymology, particularly with the determination of Vmax, KM and KI at
least for some of the substrates or products. It is well illustrated in the
measurement of the (maximal) activity of the individual complexes,
which is particularly useful in the diagnosis of mitochondrial diseases
in attributing at least in some cases the pathology to a particular defect
in a given complex as in [22]. In the same time the activity of the whole
respiratory chain (and of part of TCA cycle) is recorded classically
in very different conditions (resting state with a maximal transmem-
brane proton potential (state 4), phosphorylating state with a lower
proton potential (state 3), intermediate states between states 4 and 3,Table 1
The different equations discussed in this paper. *Ordered of binding: NADH,Q, and of release:.
Name and abbreviation Equation
Extended Reversible Henri–Michaelis–Menten
(ER-HMM equation) v ¼ Et 
k f  NADHKNADH 
Q
KQ
−kb 
1þ NADHKNADHþ
NAD
KNAD
 
1

Convenience Kinetics
(CK equation) v ¼ Et 
k f  NADHKNADH
1þ NADHKNADH
 
1þ QKQ
 
Extended Mass Action Equation
(EMA equation) v ¼ Et 
k f NADHQCS −kb 
NADQH2
CP
1þNADHQCS þ
NADQH2
CP
Ordered Mechanism *
OM(NQNQ) equation vOM ¼ Et  1þ NADHKNADH þ
NADH
KNADH
 QH2KQH2 þ
"
Ping-Pong Mechanism
PPM equation vPPM ¼ Et 
k f 
NADH
KNADH
þ QKQ
NAD
KNAD
 QH2KQH2 þ
"uncoupled state etc.). In all these physiological conditions, the concen-
trations of the substrates/products of the individual respiratory
complexes (NAD/NADH, Q/QH2, redox state of Cyt c) are also very differ-
ent and presumably also different from the concentrations used in the
determination of the (maximal) activity of the individual complexes.
This could invalidate the use of the parameter values determined in
these latter conditions (maximal activity determination in the absence
of products) for themodeling of thewhole respiratory chain functioning
at nonmaximal activity in the presence of products.
For this reasonwe studied the kinetics of the isolated respiratory com-
plexes in a broad range of substrate/product concentrations with the ﬁrst
aim to integrate the observations in a rate equation as simple as possible
but nevertheless illustrating the main characteristics of the kinetics, par-
ticularly the saturation behavior, the presence of products and the ther-
modynamic constraints. Our aim is to use these “simple” rate equations
both to model kinetics of the individual isolated complexes and also the
global behavior of the whole respiratory chain when all the respiratory
complexes are considered together. We will analyze different types of
equations already used (NET, MAL) and we will propose other
equations [23–27], more able to ﬁt the kinetics of respiratory complexes
particularlywhen involved in electron transport and proton translocation
through the whole respiratory chain: Extended Reversible Henri–
Michaelis–Menten Equation (ER-HMM), Ping Pong Mechanism (PPM),
Ordered Mechanism (OM), “Convenience Kinetics” (CK) and a new type
of equation: Extended Mass Action (EMA) (Table 1 and Fig. 1). As an ex-
ample, we will compare all these equations in their ability to model our
kinetic results already published in [28] on beef heart complex I
(NADH–Coenzyme Q reductase activity). It catalyzes the reaction:
NADH þ Hþ þ Q b¼¼N NADþ þ QH2: ð1Þ
2. Materials and methods
2.1. Preparation of mitochondria
Frozen isolated beef heart mitochondria were a gift from Dr. Joel
Lunardi, prepared according to [29]. In this preparation the ﬁnal mito-
chondrial pellets were homogenized at a concentration of 40 mg/mL
and the mitochondrial suspension was frozen in liquid nitrogen as
small beads of 50 μL volume and stored at−80 °C. In our experiments,
one bead was thawed and diluted (1/5), aliquoted and the aliquots are
frozen again. Then for each experiment an aliquot is thawed and diluted
once more (1/20) in the slightly hypo-osmotic reaction buffer in order
to ensure that the membranes are broken and their potential is null.
For the assay itself, the mitochondrial suspension was diluted again
(ﬁnal concentration: 4.4 μg mitochondrial proteins in 1 mL). All
assays were performed in a temperature-controlled single wavelength
spectrophotometer.NAD, QH2.
Equilibrium constraints
NAD
KNAD
 QH2KQH2
þ QKQþ
QH2
KQH2
 Keq ¼ k fkb  KNADKNADH  KQH2KQ
 QKQ−kb 
NAD
KNAD
 QH2KQH2
þ 1þ NADKNAD
 
1þ QH2KQH2
 
−1
Keq ¼ k fkb :
KNAD
KNADH
:
KQH2
KQ
Keq ¼ k fkb :
CP
CS
k f  NADHKNADH 
Q
KQ
−kb  NADKNAD 
QH2
KQH2
Q
KQ
þ NADKNAD þ
QH2
KQH2
þ NADHKNADH 
Q
KQ
þ NADKNAD 
QH2
KQH2
þ
Q
KQ
 NADKNAD þ NADHKNADH 
Q
KQ
 NADKNAD þ
Q
KQ
 NADKNAD 
QH2
KQH2
# Keq ¼ k fkb  KNADKNADH  KQH2KQ
NADH
KNADH
 QKQ−kb 
NAD
KNAD
 QH2KQH2
þ NADKNAD þ
QH2
KQH2
þ NADHKNADH 
Q
KQ
þ
NADH
KNADH
 NADKNAD þ
Q
KQ
 QH2KQH2
# Keq ¼ k fkb  KNADKNADH  KQH2KQ
MAL NADH + H+ + Q NAD+ + QH2
kf
kb
PPM
E              ENH E*N            E* 
NADH NAD+cat
E*           E*Q EQH2 E 
Q QH2cat
OM
(NQNQ) E           ENH ENHQ          ENQH2 EQH2 E 
NADH NAD+catQ QH2
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E
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E
EN
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ER-HMM
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ENHQ ENQH2
NADH
E
NADH QENH
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E
ENHQH2
NADH
ENQ Q
EQH2
QH2
QH2
QH2
NAD+
EN
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See Sup Mat 7
NAME MECHANISM
E + NADH + H+ + Q E*
k1
k-1
k2
k-2
E + NAD+ + QH2
Mechanism 1:
Mechanism 2:
EA + NADH + H+ + Q 
k1
k-1
k2
k-2
EB + NAD+ + QH2 ; EAEB
Fig. 1. Mechanisms associated to the rate equations. MALmeansMass Action Law. In ER-HMM (Extended Reversible-Henri–Michaelis–Menten) and in CK (convenience Kinetics) mech-
anisms, ENH means E-NADH, ENHQ: E-NADH-Q, ENHQH2: E–NADH–QH2, ENQ: E–NAD–Q, ENQH2: E–NAD–QH2, EQH2: E–QH2 and EN: E–NAD. In EMA mechanism 1, E* symbolizes an
Enzyme–Substrates–Product complex. Inmechanism2, EA and EB represent two enzyme conformations able to bind respectively the substrates only and theproducts only. The derivations
of the EMA equation are detailed in Supplementary materials 2.
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The assay was performed at 37 °C according to [22] by following the
decrease in absorbance at 340 nm resulting from the oxidation of NADH
in 1 mL of medium containing 65 mM KH2PO4 (pH 7.5), 2 mg BSA, 2
mMEDTA, 46 μM antimycin A, 4.4 μg mitochondrial protein and in con-
trol assays additionally 25 μM rotenone. A constant ethanol concentra-
tion of 8 μL/1000 μL was present in all assays. It means that the
complement to this quantity was added when not brought by the
added constituents. The concentrations of the substrates NADH and Q
(decylubiquinone) are varied, as well as the concentrations of products
NAD+ and QH2. The reaction was initiated by NADH addition. The
extinction coefﬁcient used for NADH concentration determination was
6.22 mM−1 cm−1 at 340 nm. The net activities have been obtained by
subtracting the residual activity in the presence of rotenone from the
activities without.2.3. Parameter estimations
The parameter values of the different rate equations have been
estimatedminimizing the rootmean square deviation (RMSD) between
the experimental and theoretical data points. RMSD for one set of pa-
rameters was calculated simultaneously with all experimental series
(see ﬁgures in the Supplementary materials). To ﬁnd the RMSD mini-
mum, we used a global search routine (genetic algorithm) followed by
a local one (quasi Newton based) as proposed in [30]. It permits tobrowse the whole parameter space and then to converge toward a
well deﬁned solution, usually unique in our cases. All calculations
have been done using Scilab (Scilab Enterprises, 2012 http://www.
scilab-enterprises.com/). Because the reaction catalyzed by the respira-
tory chain complex I is highly exergonic, the rate constant of the back-
ward reaction kb is simply calculated via the Haldane relationship:
Keq ¼
kf
kb
 KNAD
KNADH
 KQH2
KQ
ð2Þ
or equation
Keq ¼
kf
kb
 CP
CS
ð3Þ
for EMA with the equilibrium constant:
Keq ¼ exp −
ΔG0o
RT
 
¼ 1:54 10þ11 ð4Þ
where R= 8.314 J/mol/K. The temperature in the experimentswas T=
310 K and ΔG′o =−66.4 kJ/mol at pH 7.5 (69.4 at pH 7.0).
Table 2
Fits of the experimental points by the different saturable equations of Table 1.
The kinetic parameters are identiﬁed byminimizing the root mean square deviation (RMSD) calculated between all experimental data and the corresponding theoretical points evaluated
with the equation under study as explained in the Materials andmethods section (see Supplementary materials for the ﬁgures of all ﬁts). The kb value has been calculated using the Hal-
dane relationship with Keq = 1.541011 corresponding to ΔG′o (pH 7.5; T = 310 K) = −66.4 kJ/mol.
Equation RMSD kf kb KNADH KQ KNAD KQH2
[nmol NADH·min−1·mg−1] [μM] [μM] [μM] [μM]
PPM 162 1910 1.3·10−6 6.1 13.1 2064 4.0
OM (NQNQ) 161 1802 1.0·10−5 4.4 9.9 13,931 2.7
OM (QNQN) 162 1797 5.0·10−6 4.3 9.8 774 23.6
OM (QNNQ) 164 1801 1.9·10−5 4.4 9.7 13,087 5.3
OM (NQQN) 168 1793 9.2·10−6 4.3 9.8 1666 20.1
ER-HMM 164 1791 1.1·10−6 4.3 9.7 780 5.3
CK 167 1773 1.5·10−8 4.2 9.5 88 0.6
EMA 244 1333 1.8·10−10 CS = 166 μM2 CP = 3.4 μM2
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3.1. Non-saturable rate equations
3.1.1. Near Equilibrium Thermodynamics (NET) equation
In the near equilibrium approach the reaction velocity is assumed to
be proportional to the Gibbs energy.
vCI ¼−kCI  ΔGCI ð5Þ
with:
ΔGCI ¼ ΔG0o;CI þ RT  Ln
NAD½   QH2½ 
NADH½   Q½ 
 
: ð6Þ
This type of equation was proposed by Westerhoff [7] and used by
Korzeniewski et al. [10] for instance to model complexes I and III of
the respiratory chain.
3.1.2. The Mass Action Law equation
The MAL equation applied to the enzymatic reaction (1) reads:
vCI ¼ kf NADH½   Q½ −kb NAD½   QH2½  ð7Þ
or introducing Keq:
vCI ¼ kb Keq NADH½   Q½ − NAD½   QH2½ 
 
: ð8Þ
This type of equation was largely used for modeling the respiratory
chain complexes (e.g. [14,15]).
We conclude that these equations (see supplementary material 1),
MAL aswell as theNET equation cannot be used for an accurate descrip-
tion of respiratory complex kineticswhen there is a possible variation in
substrate and product concentrations. It is necessary to introduce a sat-
uration term in the rate equations.
3.2. The saturable rate equations
3.2.1. The equations
The list of the rate equations tested in this work which exhibit a sat-
urable pattern as a function of substrate or product concentrations is
given in Table 1 and their mechanisms are depicted in Fig. 1. They all in-
volve the same type of numerator asMAL equation vanishing at equilib-
rium (or an equivalent expression in the case of EMA). In addition, they
also involve a denominator with Michaelis constants KM for substrates
and products. Because we look for an equation as simple as possible
we assume that the KM for a substrate/product is independent of the
binding of the others which is not necessarily true in reality. Because
the denominators of the equations are different, one can predict thatthe values of KM may be different for the different equations. All these
equations but PPM are equivalent in the absence of products.
The Extended-Reversible Henri–Michaelis–Menten (ER-HMM)
equation [23–25,31–34] corresponds to a random binding/release of
substrates/products as represented in Fig. 1. It is well described in all
textbooks (see [26] for instance).
The Convenience Kinetics equation (CK) is a generic equationwhich
can account for any number of substrates and products. It has been pro-
posed by Liebermeister and Klipp [27] and includes the same basic ki-
netic parameters (linked by the same Haldane relationship) as the ER-
HMMequation above but arranged slightly differently in the denomina-
tor so that the KM values may be different. In the case of 2 substrates 2
products, it also corresponds to a random binding mechanism but, in
contrast to the ER-HMMmechanism, it is without the non-reactive ter-
nary complexes E–NADH–QH2 and E–NAD–Q (see Fig. 1).
The interests of the ER-HMMequation is well explained by Cornish–
Bowden and Hofmyer in [23] which also applies to CK: a minimal num-
ber of parameters, adherence to thermodynamic constraints, competi-
tion between substrates and their corresponding products and
saturability.
The equation given in Table 1 for the order mechanism (OM) corre-
spond to the caseNQNQmeaning that NADHbinds ﬁrst then Q andNAD
is released ﬁrst then QH2. The four possible sequences of substrate bind-
ing/product release have been tested (see Table 2).
A ping-pong mechanism was also proposed for complex I kinetics
(see the discussion in [28]). It can correspond to two situations: NNQQ
or QQNN meaning that either NADH reacts ﬁrst and gives NAD and
then Q gives QH2 or vice versa. In the simpliﬁed form where the KM
are independent of each other, both equations have the same expres-
sion given in Table 1.
Finally we tested the EMA equation (Extended Mass Action) which
is based onmass action according to two different possible mechanisms
(see supplementary material 2 for a complete derivation of this equa-
tion). It can also be seen as a simpliﬁed ER-HMM equation in which
the Michaelis constants of the substrates (resp. the products) are
fused in one constant CS (resp. CP). The equation has only 4 parameters
which arenot independent; one can be replaced by the equilibriumcon-
stant via the Haldane-like relationship (3)
This equation has the big advantage that any stoichiometric factor
(also non integer) can be included, like for the NET and MAL equations.
This equationwas developed independently by Liebermeister et al. [35].
For each equation, the results of parameter ﬁtting using all the ex-
perimental points are listed in Table 2. Fig. 2e to h gives an example of
these ﬁttings in the case of ER-HMM and EMA equation with only
some of the experimental points. The ﬁgures showing the results of
the ﬁttings according to other saturable rate laws with the complete
set of experimental points are shown in the Supplementary materials.
The results are always plotted in comparison with the ER-HMM ﬁt
(blue dashed).
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give nearly the same good accuracy. The rate constants and the sub-
strate KM values are also very similar (except for EMA for which the0
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1712 M. Heiske et al. / Biochimica et Biophysica Acta 1837 (2014) 1707–1716products. The determination of the products KM is more difﬁcult be-
cause as mentioned above, the complex I reaction is largely irreversible
in the absence of ΔμH+. The only way to have an indication of the prod-
ucts KM is to record the reaction rate in the forward direction in the
presence of different concentrations of the products (Fig. 3). The values
of the products KM are dependent on the structure of the denominator
of each equation, but still one can state that KNAD is clearly high and dif-
ﬁcult to measure indicating a low afﬁnity of NAD+. On the other hand
KQH2 is rather low, sometimes lower than KQ. Both KM products depend
upon the rate equation used to ﬁt the experimental results.
3.2.2. Q inhibition
Fig. 4 shows a clear inhibition at high Q concentration (N100 μM).
Different types of substrate inhibitions can be considered such as non-
competitive, substrate/steric inhibition (at the normal binding site).
On the example of ER-HMM equation, several inhibition terms have
been tested. The ER-HMM equation reads then:
v ¼ Et  Inc 
kf 
NADH
KNADH
 Q
KQ
−kb 
NAD
KNAD
 QH2
KQH2
1þNADH
KNADH
þ NAD
KNAD
 
1þ Q
KQ
Is þ
QH2
KQH2
Is
 ! ð9Þ
with the inhibition terms Is and Inc described in the following.0
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Fig. 3. Product inhibition. a: NAD inhibitionwith NADH=38 μMandQ=69 μM. (See also
ﬁgures z to ac in the Supplementary materials. This ﬁgure corresponds to ﬁgure ac with
the ER-HMM equation.) b: QH2 inhibition with NADH = 28.5 μM and Q = 54.5 μM. (See
also ﬁgures v and w in the Supplementary materials. This ﬁgure corresponds to ﬁgure w
with ER-HMM equation.) The ﬁtting curve is represented by a continuous red line.3.2.2.1. Substrate-product or steric inhibition Is. This type of inhibition cor-
responds to the obstruction of the catalytic site of quinone reduction by
quinone or quinol. Assuming that Q and QH2 obstruction has the same
effect on thebinding of bothmolecules QH2 or Q, the term Is can bewrit-
ten:
IS ¼ 1þ
Q½ 
Ki1
þ QH2½ 
Ki2
ð10Þ
where Ki1 and Ki2 are the inhibition constants of Q andQH2 respectively.
In the case where Ki1 = Ki2 = Ki, the expression (10) becomes:
IS ¼ 1þ
Qtot½ 
Ki
where Qtot½  ¼ Q½  þ QH2½ : ð11Þ
3.2.2.2. Noncompetitive inhibition Inc. Another possibility is that Q or/and
QH2 bind to a second quinone site on themolecule, modifying the activ-
ity of complex I, giving rise to a non-competitive inhibition.
The generic expression of a non-competitive inhibition is:
Inc ¼
1
1þ Q½ Ki1 þ
QH2½ 
Ki2
0
@
1
An: ð12Þ
The values n= 1 and n= 2 have been tested with inhibition by Qtot
(with Ki1 = Ki2 = Ki) or Q alone.
All the experimental points have been ﬁtted by ER-HMM Eq. (9)
involving different Is or Inc terms listed in Table 3 (see supplementary
materials Figs. 7 and 8).
Very similar accuracies of the different ﬁts are obtained. In the case
of steric inhibition, taking Q and QH2 separately or Qtot as an inhibitor
makes no real difference (not shown). It is the same in the case of
non-competitive inhibition. In this latter case taking n = 1 or n = 2
gives similar ﬁts. The steric (red broad line) and non-competitive
(black thin line) inhibitions are represented on Fig. 4 and overlap. The
curve without inhibition (blue dashed line) is also shown for compari-
son. Interestingly the values of KQ (and of KNADH) remain approximately
the same for all types of inhibition. Only KQH2 changes signiﬁcantly
when part of the normal (product) QH2 inhibition is taken by the specif-
ic inhibitory mechanism.
4. Discussion and conclusion
4.1. NET and MAL rate equations
As obvious in Fig. 2 (a to d), Near Equilibrium Thermodynamics (NET)
and Mass Action Law (MAL) rate equations fail to adequately represent
the activity of complex Iwhen the concentrations of substrates are varied.
In the case of NET, the logarithmic term dampens the variations of sub-
strate concentrations so that the rate value is nearly constant (between
540 and 650 nmol·min−1·mg·prot−1) over the nearly two order of
magnitude of substrate concentrations used. Only at a very low concen-
tration of one substrate, the rate decreases rapidly toward zero (in fact
to minus inﬁnity; see the red line along the y-axis in Fig. 2a and b). It is
not surprising because in conditions of very low product concentrations
(0.1 μM each in our case to make the calculation possible) with a value
of ΔG′o =−66.4 kJ, the reaction is far from equilibrium and its rate will
not obey the conditions of near Equilibrium Thermodynamics.
A slightly better ﬁt is obtained with the MAL equation, because in
this case the rate equation is sensitive to substrate concentration varia-
tions. However the linear increase of the rate as a function of substrate
concentrations does not correspond to the reality of saturable kinetics.
For comparison the ﬁt of the same points with a typical saturable
kinetic equation (ER-HMM, Fig. 2e–f) is shown. However NET and
MAL equations may be a good choice for the description of the respira-
tory chain in conditions close to equilibrium which can be the case
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Fig. 4. Complex I inhibition by the substrate Q. The curves are drawn according to the ER-
HMM equation (Eq. 13) with the parameters of Table 2 in the absence of Q substrate
inhibition ( ) and with the term Is = 1 + Q/KI (red large line) with the parameters
of Table 3, second row (kf = 2194, KNADH = 4.5 μM, KQ = 14.7 μM, KNAD = 743 μM,
KQH2=7.5 μMandKI=576 μM)orwith the term Inc=1/(1+Q/KI) (thin black line over-
lapped by the red one) with the parameters of Table 3, third row (kf = 2254, KNADH =
4.5 μM, KQ = 15.1 μM, KNAD = 743 μM, KQH2 = 7.6 μM and KI = 561 μM). The black
diamonds correspond to the experimental points at (a) NADH = 28.5 μM, (b) NADH =
47.5 μM. (c) depicts the rate as a function of QH2 with NADH = 28.5 μM and Q =
45.5 μM with steric inhibition ( ) or noncompetitive inhibition (____ superimposed
with the previous one ) or without any inhibition ( ). The ﬁts of the other inhibi-
tory function are very similar (not shown). See also Figs. S5 and S6 in Supplementary
materials.
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ΔμH+ ≠ 0. It must be stressed that in all cases, the constants involved in
these equations (kCI or kf) get ad hoc values which do not correspond
to any intrinsic property (kinetic constants) of the respiratory com-
plexes. Nevertheless, as demonstrated by Pillay et al. [36], a MAL
model can give rise to a “saturation” behavior particularly in redox cy-
cleswhen the sumof the redox couples (NAD/NADHandQ/QH2) is con-
stant. In these conditions, the maximal velocity depends upon the rate
constant and the total concentrations of substrates/products and the
half saturation concentration also depends upon the total concentration
of the redox couples and is thus variable and different from a real KM.
Using such equations will make it difﬁcult to analyze the effect on
OXPHOS of a variation of a particular kinetic parameter (kcat or KM) of
a given respiratory complex or of physiological or pathological changes
in total substrate and product concentrations.
On the contrary Fig. 2e–h (and Figs. 3 to 8 in the Supplementaryma-
terials) and Table 2 show that all the other equations tested in our study
give similar good ﬁts when compared with the whole set of our exper-
imental data. It should be however noticed that the EMA ﬁt, which in-
volves two parameters less, is less accurate mainly because it does not
have independent saturation terms for each of the substrates/products.
Their binding is rather considered simultaneous (see the Supplementa-
ry materials) and quantiﬁed by the phenomenological constants CS and
CP. When the KM of substrates (respectively the products) are similar
the phenomenological constants C represent adequately their associa-
tion by an average constant. It is no longer the casewhen the KM are dif-
ferent as here for NAD and NADH.
4.2. Kinetic mechanism and kinetic constants
The striking result of this study that several kinetic equations are
equally able to ﬁt the experimental results over large concentrations
of substrates and products is consistent with the fact that the kinetic
mechanism of this reaction is still a matter of discussion. It means that
this form of analysis does not shed light on the, too complex, kinetic
mechanism of the reaction. Fato et al. [37] proposed a ping-pongmech-
anism in the case of mitochondria isolated from bovine heart with the
oxidation of NADH preceding the reduction of ubiquinone. Nakashima
et al. [38] used CoQ1 as the electron acceptor to analyze the activity of
complex I puriﬁed from bovine heart. They proposed an ordered se-
quential mechanismwith CoQ1 binding as the ﬁrst step and CoQ1H2 re-
leasing as the last step. Hano et al. [39] assumed that the kinetics of
complex I obeys an ordered sequential mechanism when they used
decylubiquinone (DQ) as the electron acceptor.
Analyzing the same set of experimental results as in this study in the
light of a stochastic model based on Gillespie's approach [40] and taking
into account the structure (distances) and the midpoint potentials of
the reaction centers we showed that the kinetics may not necessarily
obey a simple mechanism (ordered or ping-pong) [28]. This is particu-
larly due to the substantial distance (around 90 Å) between the NADH
oxidation site and the quinone reduction site and the presence of
seven redox reactions in between. It makes the two extreme redox
sites (NADH/NAD on the one hand and Q/QH2 on the other hand) as if
they were independent from each other. The stochastic simulations
also evidenced a plateau for saturating NADH concentrations (see ﬁgures
a–j in Fig. S3 to S8). It renders the ﬁt by any equation used in this study
slightly inaccurate: at high NADH concentrations the theoretical curves
go on increasingweakly, while the experimental rates (aswell as the sto-
chastic simulations) are steady and quasi horizontal.We showed that this
does not result from a substrate inhibition but simply from the accumula-
tion of electrons in the intermediate redox centers asNADHconcentration
increases, leading to a sort of electron buffering effect [28].
This can be easily understood in the following way: if the rate of the
second half of the mechanism (Q QH2) is low as compared to the ﬁrst
one (NADH NAD) and to the intermediate redox reactions inside com-
plex I, for instance lowQ and high NADH, then the electrons accumulate
Table 3
Competitive/steric and non-competitive inhibition of complex I by quinones. The table lists the results of ﬁtting all the experimental data with an inhibition term in the ER-HMMequation
(Eq. (10)) as explained in the text. The ﬁtting method is the same as in Table 2. When there is only one inhibitory constant, it is called Ki and listed in Ki1 column. The kb value has been
calculated using the Haldane relationship as in Table 2.
Inhibition RMSD kf kb KNADH KQ KNAD KQH2 Ki1 Ki2
[nmol NADH·min−1·mg−1] [μM] [μM] [μM] [μM] [μM] [μM]
Is ¼ 1þ QKi1 þ
QH2
Ki2
151 2185 7.42·10−6 4.5 14.7 740 46.9 598 25.4
Is ¼ 1þ QtotKi 153 2194 1.20·10
−6 4.5 14.7 743 7.5 576
Inc ¼ 11þQtotKi
153 2254 1.21·10−6 4.5 15.1 743 7.6 561
Inc ¼ 11þQKi
154 2244 1.07·10−6 4.5 15.0 744 6.7 575
Inc ¼ 11þQtotKi
 2 153 2209 1.18·10−6 4.5 14.7 740 7.4 1319
Inc ¼ 11þQKi
 2 154 2200 1.07·10−6 4.5 14.5 741 6.6 1351
Inc ¼ 1
1þ QKi1þ
QH2
Ki2
152 2236 1.04·10−5 4.5 15.0 741 65.6 589 29.8
Inc ¼ 1
1þ QKi1þ
QH2
Ki2
 !2 151 2198 2.83·10−5 4.5 14.6 737 177 1367 56.8
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reactions. As soon as one QH2 molecule is formed, two electrons from
some FeS centers are again rapidly available. The limiting step is the re-
lease of the previously formedQH2molecule and the binding of the new
Qmoleculewhich are phenomenamuch slower than the “ﬂitting” of the
electrons between the FeS centers and operating at a constant rate
whenQ andQH2 are constants. In otherwords,when the secondhalf re-
action is slower than the ﬁrst one, there are always two electrons to re-
duce a Q molecule when present. It is the reason why a plateau is
observed in the kinetics particularly at high NADH and low Q.
Another salient feature of our study is that for all the saturable
equations (but EMA) the maximal rate constants and the KM are
nearly the same (see Table 2) and well comparable with the data in
the literature on beef heart mitochondria complex I. For instance
we ﬁnd a forward maximal rate constant between 1773 and
1910 nmol·NADH·min−1·mg−1. Fato et al. [37] determined on submi-
tochondrial particles for different types of quinone a kcat ranging from
170 to 1560 nmol·NADH·min−1·mg−1. Sherwood and Hirst [41] re-
ported a value of 3100 nmol·NADH·min−1·mg−1 and Hano et al. [39]
a value of 1860 nmol·NADH·min−1·mg−1. Lower values around
500 nmol·NADH·min−1·mg−1 were reported by other authors with
different quinone analogs [42].
KM (NADH) was found in the range of 0.6–2.7 μM on isolated com-
plex I in the presence of different quinone types, among them also
decylubiquinone [38,39], always in beef heart mitochondria. For SMP a
value of 9.2 μM has been found [37]. Vinogradov [43] reported for KM
(NADH) 7.6 μM and 7.2 μM for coupled and uncoupled SMPs, respec-
tively. Nakashima et al. [38] founda KM (NADH) around2 μMdepending
on Q1 and NAD concentrations. It is well comparable with the values
4.2–6.1 μMwe found in our ﬁts.
The values found for KM (Q) are more variable, due to the different
types of quinone that has been used. Fato et al. [37] determined the KM
(Q) for 7 different types of quinones on bovine submitochondrial parti-
cles. Their values for decylubiquinone (DQ) were found to be 1.8 and
2.1 μM. A higher value of 24 μMhas also been reported in [41]. For com-
plex I isolated from beef heart, values of 4.4–12.9 μM for Q1 and Q2 [38,
39,44] have been reported and 51 μM [39] for decylubiquinone. These
values are similar to the values between 9.5 and 13.8 found in our ﬁts.
Less data are available with respect to the KM values of the products
and they aremore difﬁcult to compare to our values because of their de-
pendence on the rate equation structures. Vinogradov [45] found a Ki
value for NAD of 1250 μM on uncoupled SMP, which lies among the K-
values we found for the different equations. However, for the reversereaction under coupled conditions the author reported a KM of 7.2 μM
for NAD. To explain the difference of about three orders of magnitude
it was suggested that NAD binds to a different site for the reverse
sense. But this large difference may also be due to the equation that
has been used for the determination of these values, as we can see on
Tables 2 and 3.
With only three independent parameters (instead of ﬁve for the
other equations, ER-HMM, PPM or OM), the EMA equation is a signiﬁ-
cantly less precise description of the given data. However, for most
data curves EMA is still comparable to the other rate equations, as one
can see in Fig. 2 and on Fig. 4 in Supplementary Material. But since the
product inhibition by QH2 and NAD+ are approximately three orders
of magnitude apart, it is obvious that EMA cannot describe accurately
the inﬂuence of both. Here the ﬁts lead to a good description of the in-
ﬂuence of QH2, but in contrast, in the series where NAD+ was varied
the data description is not satisfactory. For the latter noQH2was present
which means that the product term in the EMA equation was always 0,
with NAD+ present or not. Hence EMA is not applicable to such an ex-
treme situation4.3. Inhibition by Q
In our experimental data one can observe an inhibition of complex I
at high concentrations of decylubiquinone (Fig. 4). Indeed oxidized qui-
nones have been suspected to exert a negative effect on complex I activ-
ity at higher concentrations. Lenaz et al. [46] showed an inhibitory effect
by the short chain CoQ analog Q3 and assumed that there is a need for
long chain ubiquinone for a proper functioning of complex I. Other au-
thors reported this inhibition with different types of quinones [37,44].
Grivennikova et al. [18] reported even a very strong inhibition by the
short chain ubiquinone. This could suggest the existence of a second in-
hibitory site for quinone (oxidized) in addition to the substrate site as
we already discussed in [28] (see also [41,44,47–50]). Although, there
is no evidence of a precise second ubiquinone site, there is the possibil-
ity of ubiquinone taking several positions either in the large reaction
pocket or on the way leading from the membrane to the reaction site
and thus impeding or hindering the access of the ubiquinone substrate
by ubiquinol or the release of the ubiquinol product by ubiquinone, well
modeled by a steric inhibition either by Q or QH2. It should be noticed
that the inhibitory concentration of Q is rather high (N100 μM) and
that 15–20% inhibition is obtained at 350 μM Q. Thus the inhibition
term can be presumably neglected in most of the cases.
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Because all equations but EMA give a similar good ﬁt of our kinetic
experiments performed with large variations of the substrates and
products, we select the ER-HMM equation to represent complex I activ-
ity. It is among the simplest and corresponds to the randombi–bimech-
anism. As noted above, the inhibitory term is probably most of the time
superﬂuous. If necessary, it will be added under the form of a noncom-
petitive inhibition by Qtot. Both types of inhibition (non competitive and
steric) give a very comparable inhibitory pattern (Figs. 7 and 8 in Sup-
plementary Material).
v ¼ Et:Inc :
kf :
NADH
KNADH
:
Q
KQ
−kb:
NAD
KNAD
:
QH2
KQH2
1þ NADH
KNADH
þ NAD
KNAD
 
1þ Q
KQ
þ QH2
KQH2
 ! ð13Þ
with
Inc ¼
1
1þ Qtot½ 
Ki
0
BB@
1
CCA ð14Þ
Wehave shown that this type of equation (ER-HMM) can be used to
ﬁt the kinetics of the other complexes of the respiratory chain [51].
In a forthcoming paper we will discuss the introduction of the pro-
ton gradient in biothermokinetic rate equations and analyze different
approaches with respect to their ability to reproduce OXPHOS data
under coupled conditions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbabio.2014.07.013.
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